Diverse antibody drugs
to novel, highly
selective tumor targets

View our pipeline

Diverse antibody drugs
to novel, highly
selective tumor targets

View our pipeline

news

Resonant Therapeutics Announces Collaboration with Janssen | Business Wire

Read more

Retrogenix and Resonant Therapeutics Announce Strategic Alliance to Identify Targets of Anti-Tumor Antibodies

Read more

Resonant Therapeutics Announces Advancement in Collaboration with Janssen

Read more
© 2017 - 2022 Resonant Therapeutics